Continuing Education
2025 Therapeutic Updates
Best Suited For: Pharmacist, Pharmacy Technician
CE Credits: 1 hours
Activity Description
The goal of this activity is to provide pharmacists, pharmacy technicians, and nurses a with a comprehensive overview of newly FDA-approved therapies in 2025. The session will review new oncology drugs, including mechanism of action, safety, dosing and administration instructions. Participants will gain knowledge and understanding of these newly approved therapies and their place in clinical practice.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Review FDA approved indications of some oncology drugs from 2025
- Explain the mechanism of action of new oncology drug classes approved in 2025
- Summarize clinical trial data that led to the new oncology drug approvals in 2025
- Describe safety & monitoring of the new oncology drugs approved in 2025
- Discuss the place in therapy of the new 2025 oncology drug approvals with current therapies
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted will be viewable in your CPE Monitor profile within 24 hours.
